Q1 2025 Holdings
Filed 2025-05-15 | 102 holdings | $383.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc(AMGN)Call | COM | 031162100 | $32.2M | 103,300 | 8.4% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $22.8M | 900,000 | 6.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $18.9M | 29,828 | 4.9% |
| Corcept Therapeutics Inc(CORT)Put | COM | 218352102 | $17.2M | 150,200 | 4.5% |
| ELI Lilly & Co(LLY)Put | COM | 532457108 | $17.1M | 20,700 | 4.5% |
| Amgen Inc(AMGN)Put | COM | 031162100 | $16.2M | 52,100 | 4.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $15.9M | 19,302 | 4.2% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $15.7M | 219,400 | 4.1% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $15.5M | 217,000 | 4.0% |
| Regeneron Pharmaceuticals(REGN)Put | COM | 75886F107 | $12.7M | 20,000 | 3.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $10.8M | 87,189 | 2.8% |
| Jazz Pharmaceuticals PLC(JAZZ)Call | SHS USD | G50871105 | $8.8M | 70,800 | 2.3% |
| Novo-Nordisk A S(NVO)Put | ADR | 670100205 | $8.7M | 124,600 | 2.3% |
| ELI Lilly & Co(LLY)Call | COM | 532457108 | $8.3M | 10,000 | 2.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.2M | 207,883 | 2.1% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $7.5M | 108,700 | 2.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $7.2M | 12,279 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.9M | 62,247 | 1.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.6M | 93,002 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $5.4M | 20,000 | 1.4% |
| Apogee Therapeutics Inc(APGE)Call | COM | 03770N101 | $4.7M | 126,300 | 1.2% |
| Corcept Therapeutics Inc(CORT)Call | COM | 218352102 | $4.6M | 40,000 | 1.2% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $4.5M | 131,400 | 1.2% |
| Ultragenyx Pharmaceutical in(RARE)Put | COM | 90400D108 | $4.5M | 123,300 | 1.2% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $4.2M | 117,000 | 1.1% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $3.8M | 112,000 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $3.7M | 52,877 | 1.0% |
| Recursion Pharmaceuticals in(RXRX)Call | CL A | 75629V104 | $3.7M | 698,400 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.5M | 13,115 | 0.9% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $3.5M | 119,700 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.5M | 92,385 | 0.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $2.9M | 96,984 | 0.8% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $2.8M | 100,000 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.6M | 50,000 | 0.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.6M | 60,000 | 0.7% |
| Mannkind Corp(MNKD)Call | COM NEW | 56400P706 | $2.6M | 519,900 | 0.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.5M | 104,121 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.4M | 164,048 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.3M | 392,213 | 0.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.2M | 162,063 | 0.6% |
| Anaptysbio Inc(ANAB)Put | COM | 032724106 | $2.2M | 117,300 | 0.6% |
| Edgewise Therapeutics Inc(EWTX)Call | COM | 28036F105 | $2.2M | 98,200 | 0.6% |
| Zymeworks Inc(ZYME)Call | COM | 98985Y108 | $2.1M | 179,300 | 0.6% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $2.1M | 418,800 | 0.5% |
| Vaxcyte Inc(PCVX)Put | COM | 92243G108 | $1.9M | 51,600 | 0.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.9M | 57,923 | 0.5% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $1.8M | 96,800 | 0.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.7M | 231,436 | 0.4% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $1.7M | 24,618 | 0.4% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $1.6M | 154,100 | 0.4% |